Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
NEW YORK (GenomeWeb) – PGXL Technologies today said that it has formed a partnership with NX PharmaGen under which the partners have created a research center focused on exosome analysis.
NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.
NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.
This article has been updated to include information about a competing product in the market.
PGXL, a Louisville, Ky.-based pharmacogenomics services provider, plans to introduce other AutoGenomics assays, such as its KRAS-BRAF test, in the future.
Starting next month, PGXL and Generation Health will provide pharmacogenetic testing and diagnostic services to patients through healthcare providers.
An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.
The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.
In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.
Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.